EGFR and neoplasm: For assessment of variant agreement between plasma and tumor samples in clinically relevant genes; hotspot variants in EGFR (7), KRAS (11), and PIK3CA (1), and fusions in ALK (3) and ROS1 (1) were detected in tumor samples.